Synthetic mushrooms are gaining traction as a treatment for depression.  A new study suggests Psilocybin, the psychedelic chemical found in so-called magic mushrooms, may help treat depression in some patients.

This isn’t the first study of its kind — but as a randomized control trial with more than 230 participants, it’s the largest and most robust to date. The good news: the intervention worked. The highest dose produced almost immediate results — with more than one-third of those who got the intervention seeing improvements the day after.

Researchers said a 25 mg one-time dose of the synthetic formulation of psilocybin reduced depression scores significantly in patients, but was associated with some adverse side effects including headache, nausea and dizziness.

Could this help your patients?  Read more here.